New Technologies in Drug Development Provide New Hope in Targeting of Dysregulated Redox Signalling in Cardiovascular Disease
Crossref DOI link: https://doi.org/10.1007/978-981-13-8946-7_21
Published Online: 2019-11-11
Published Print: 2019
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saleh, Soloman
Bubb, Kristen
Figtree, Gemma A.
Text and Data Mining valid from 2019-01-01
Chapter History
First Online: 11 November 2019